IntelliPharmaCeutics International Inc. (IPCI) At $0.82 Forms Bottom; Last Week Stornoway Diamond (TSE:SWY) Analysts

January 3, 2018 - By Shannon Black

Among 5 analysts covering Stornoway Diamond Corporation (TSE:SWY), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Stornoway Diamond Corporation had 17 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of Stornoway Diamond Corporation (TSE:SWY) earned “Outperform” rating by RBC Capital Markets on Thursday, November 24. The rating was maintained by RBC Capital Markets on Tuesday, November 15 with “Outperform”. The stock of Stornoway Diamond Corporation (TSE:SWY) has “Outperform” rating given on Thursday, November 24 by Scotia Capital. The rating was maintained by Scotia Capital on Thursday, August 18 with “Outperform”. Scotia Capital maintained Stornoway Diamond Corporation (TSE:SWY) rating on Wednesday, November 16. Scotia Capital has “Outperform” rating and $1.35 target. The firm has “Outperform” rating by RBC Capital Markets given on Wednesday, August 19. RBC Capital Markets maintained it with “Outperform” rating and $1.50 target in Friday, August 26 report. The firm has “Buy” rating given on Wednesday, February 8 by Desjardins Securities. The rating was maintained by Scotia Capital on Friday, August 12 with “Outperform”. As per Thursday, August 11, the company rating was maintained by TD Securities. See Stornoway Diamond Corporation (TSE:SWY) latest ratings:

17/08/2017 Broker: TD Securities Rating: Hold Old Target: $0.90 New Target: $0.85 Target Down

IntelliPharmaCeutics International Inc. (IPCI) formed multiple bottom with $0.80 target or 3.00% below today’s $0.82 share price. IntelliPharmaCeutics International Inc. (IPCI) has $28.11M valuation. The stock decreased 2.51% or $0.0211 during the last trading session, reaching $0.8206. About 15,016 shares traded. IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) has risen 16.57% since January 3, 2017 and is uptrending. It has underperformed by 0.13% the S&P500.

Stornoway Diamond Corporation engages in the mining, acquisition, and exploration of diamond properties in Canada. The company has market cap of $551.27 million. The Company’s principal project is the Renard diamond project located in north-central Quebec. It has a 11.38 P/E ratio.

The stock decreased 1.49% or $0.01 during the last trading session, reaching $0.66. About 73,745 shares traded. Stornoway Diamond Corporation (TSE:SWY) has 0.00% since January 3, 2017 and is . It has underperformed by 16.70% the S&P500.

Analysts await IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) to report earnings on February, 9. They expect $-0.10 EPS, up 28.57% or $0.04 from last year’s $-0.14 per share. After $-0.08 actual EPS reported by IntelliPharmaCeutics International Inc. for the previous quarter, Wall Street now forecasts 25.00% negative EPS growth.